Update on acquisition of 70% stake in Derren Healthcare Private Limited.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Genpharmasec Limited has completed the acquisition of a 70% stake in Derren Healthcare Private Limited (DHPL) on 25 July 2025, making DHPL a subsidiary of the company. The deal, originally initiated through a Share Purchase Agreement and Share Subscription cum Shareholders Agreement signed on 19 September 2023, was closed at a total cash consideration of INR 34.15 crore. DHPL operates in pharmaceutical formulations and also runs a CRO/CDMO business serving Indian and international pharma companies. The acquisition is aimed at expanding Genpharmasec's footprint into formulation manufacturing. DHPL has shown strong revenue growth, with turnover rising from INR 70.24 lakh in FY23 to INR 627.69 lakh in FY24 and INR 858.82 lakh in FY25. The transaction is not a related-party deal and was carried out at arm's length.
This is a strategic move into pharma formulations and research services, giving Genpharmasec a revenue-generating subsidiary with rapid growth momentum. Shareholders should monitor integration progress and the impact on consolidated financials, given the relatively high consideration paid compared to DHPL's current turnover base.